[The effect of vasodilators on the intraocular pressure (author's transl)].
D000281:Administration, Intranasal; D000284:Administration, Oral; D001593:Benzyl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003508:Cycloheptanes / Q000627:therapeutic use; D004123:Dimethylamines / Q000627:therapeutic use; D004596:Electroretinography; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007429:Intraocular Pressure / Q000187:drug effects*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D013607:Tablets; D013997:Time Factors; D014065:Tonometry, Ocular; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001593:Benzyl Compounds; D003508:Cycloheptanes; D004123:Dimethylamines; D013607:Tablets; D014665:Vasodilator Agents; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate
Die Wirkung gefässerweiternder Medikamente auf den i.o. Druck